Susceptibility of natural killer (NK) cells to reactive oxygen species (ROS) and their restoration by the mimics of superoxide dismutase (SOD)

Cancer Biotherapy and Radiopharmaceuticals

Volumn 13, Issue 4, 1998, Pages 275-290

  Nakamura, Kunie ^a   Matsunaga, Ken Ichi ^b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KUREHA CORPORATION   (Japan)

Author keywords

Cancer bearing rat; LGL; NK cell; Oxidative stress; Reactive oxygen species; SOD mimics

Indexed keywords

GAMMA INTERFERON; MONOCLONAL ANTIBODY; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TALAPORFIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL ACTIVITY; FEMALE; HORMONE BLOOD LEVEL; NATURAL KILLER CELL; NONHUMAN; NUCLEIC ACID METABOLISM; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0031789804     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1998.13.275     Document Type: Article

References (35)

1. Dionisi O, Galleotti T, Terranova T, and Azzi A. Superoxide radicals and hydrogen peroxide formation in mitochondria from normal and neoplastic tissues. Biophysica Biochemica Acta 1975;403:292-300.
2. Peskin A, Koen YM and Zbarsky IB. Superoxide dismutase and glutathione peroxidase activities in tumors FEBS Letters 1977;78(1):41-45.
3. Bozzi A, Mavelli I, Agro AF, Strom R, Wolf AH, Mondovi B. Rotilio G. Enzyme defence against reactive oxygen Derivatives derivatives. Mol Cellul Biochem 1976;10(1):11-16.
4. Westman NG, Marklund SL. Copper-and zinc-containing superoxide dismatase and manganese-containing superoxide dismutase in human tissue and human malignant tumors. Cancer Res 1981; 41 : 2962-2966.
5. Hansbrough JF and Eisen B. Immunosuppression with hyperbaric oxygen Surg Forum 1979;30:313-315.
6. Ball SS, Weindruch R, Walford RL. Antioxidants and the immune response Free Radicals, Aging and Degenerative Diseases. Johnson JE, Eds., Alan R. Liss, Inc, p.427-456, 1096.
7. Kariya K, Nakamura K, Nomoto K, Matama S, Saigenji K. Mimicking of superoxide dismutase activity by protein-bound polysaccharide of Coriolus versicolor QUEL, and oxidative stress relief for cancer patients. Mol Biother 1992;4:40-46.
8. Kobayashi Y, Kariya K, Saigenji K, and Nakamura K. Oxidative stress relief for cancer-bearing hosts by the protein-bound polysaccharide of Coriolus versicolor QUEL with SOD mimicking activity. Cancer Biotherapy 1994;9(1).55-62.
9. Kobayashi Y, Kariya K, Saigenji K, Nakamura K. Suppression of cancer cell growth in vitro by the protein bound polysaccharide of Coriolus versicolor QUEL (PS-K) with SOD mimicking activity. Cancer Biotherapy 1994;9(1):63-69.
10. Kobayashi Y, Kariya K, Saigenji K, and Nakamura K. Suppressive effects on cancer cell proliferation of the enhancement of superoxide dismutase (SOD) activity associated with the protein-bound polysaccharide of Coriolus versicolor QUEL. Cancer Biotherapy 1994; 9(2):171-178.
11. Kobayashi Y, Kariya K, Saigenji K. Nakamura K. Enhancement of anti-cancer activity of Cisdiamine-dichloroplatinum by the protein-bound polysaccharide of Coriolus versicolor QUEL (PS-K) in vitro. Cancer Biotherapy 1994;9(4):351-358.
12. Hansson M, Asea A, Ersson U, Hermodsson S, Hellstrand K. Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. J Immunol 1996;156:41-47.
13. Kariya K, Nakamura K, Nomoto K, Kobayashi Y, Namiki M. Superoxide dismutase (SOD) activity with Fe-chlorin e6-Na and suppression of Malignant tumor growth in rats. Cancer Biotherapy 1995;10(2):139-145.
14. Nakamura K, Kobayashi Y, Kashima Y, Namiki M. Effects of iron-iron chelating cationic porphyrin derivatives superoxide dismutase (SOD) activity on cancer cells in vitro. Porphyrin 1994;3(2 & 3) 159-167.
15. Kobayashi Y, Namiki M, Nakamura K. Cationic chlorophyl derivatives with SOD mimicking activity suppress the proliferation of human ovarian cancer cells. Cancer Biother & Radiopharmaceut 1996;11(3):197-202.
16. Terasaki T, Tanaka A, Izawa M, Shimosato Y. Electron microscopical observation of on the surface of Ehrlich ascites tumor cells. Cell Structure & Function 1988; 13(3):235-240.
17. Tsukagoshi S. Host-mediated antitumor activity of polysaccharides with special reference to the effect of PS-K A protein bound polysaccharides with isolated from basidiomycetes. Jpn J Cancer Chemotherapy 1974; 1:251-257.
18. Goto T, Herberman RB, Maluish A, and Strong DH. Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity. J Immunology 1983;130(3):1350-1355.
19. 2: the role of T-cells. Cell Immunol 1984;87(1): 65-72.
20. 2 synthesis and implications for natural killer cell activity. Int J Vitamin Nutr Res 1984;54(4): 339-342.
21. Lala PK, Parhar RS, Singh P. Indomethacin therapy abrogate the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. Cell Immunol 1986;99(1):108-118.
22. Tsukagoshi S, Ohashi O. Protein-bound polysaccharide preparation, PS-K, effective against mouse sarcoma-180 and rat ascites hepatoma AH-13 by oral use. GANN 1974; 65:557-558.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin Phenol Reagent. Biological Chemistry 1951;193:265-268.
24. Hodge JE, Hofreiter BT. Methods in Carbohydrate Chemistry, edited by R.L.Whistler & Wolfrom, M. I. Vol. 1, p338, Academic Press Inc., New York, 1962.
25. Matsunaga K, Monta I, Iijima H, Endo H, Oguchi Y, Yoshimura M, Fujii T, Yoshikumi T, Nomoto K. Effects of biological response modifiers with different modes of action used separately and together on immune responses in mice with syngeneic tumours. J Int Medical Research 1992;20: 406-421.
26. Takasaki S, Mizuochi T. Kobata A. Hydrazinolysis of asparagine-linked sugar chains to produce free oligosaccharide. In: Methods in Enzymology, edited by Ginsburg, V., vol 83, p.263-268, 1982, Academic Press, New York.
27. Saji S, Umemoto T, Sugiyama Y, and Yamada M. Indication of immunochemotherapy using PSK for gastric cancer from the standpoint of host factors and studies of antitumor effects and PSK mechanism. Biotherapy (Tokyo) 1991;5.1996-2004.
28. Reynolds CW, Timonen T, Herberman RB. Natural Killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells. J Immunology 1981; 127(1):282-293.
29. 1-treated rat. J Immunology 1983;131(2):1024-1027
30. 1 I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunology 1981;127(1):34-38.
31. Weigent DA, Stanton J, Johnson HM. Recombinant gamma interferon enhances natural killer cell activity similar to natural gamma interferon. Biochem Biophys Res Commun 1983;111:525-528.
32. Raulet DH, Held W. Natural killer cell receptors: the offs and ons of NK cell recognition. Cell 1995,82: 697-700.
33. Okada F, Hosokawa M, Hamada JL, Hasegawa J, Mizutani M, Takeichi N, Kobayashi H. Progression of a weakly tumorigenic mouse fibrosarcoma at the site of early phase of inflammation caused by plastic plate. Jpn J Cancer Res 1993;84:1230-1236.
34. Rook AH, Kehrl JH, Wakefield LH, Roberts AB, Sporn MB, Burlington DB, Lane C, Fauci AS. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon respponsiveness. J Immunol 1986; 136:3916-3820.
35. Hauser GJ, McIntosh JK, Travis WD, and Rosenberg SA. Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy. Cancer Res 1990;50:3503-3508.